This BioWednesday event, led by tranScrip will discuss how investors and entrepreneurs evaluate small companies for investment. We will give you hints and tips to take away that will help inform your critical decisions. We will explore how companies managed to navigate the hurdles towards the clinic, what made the difference, pain points, and bugbears.
When
March 8th, 2023 3:00 PM to 7:30 PM
Location
Queen Edith Room
The Cambridge Building, Babraham Research Campus
Babraham
Cambridge, Cambridgeshire CB22 3AT
United Kingdom
Chair
Judit Molnar | Senior Partner, Early Development | tranScrip
Contributors
Anne Phelan | CSO | Benevolent AI
Bradley Hardiman | Head of EU Search & Evaluation | Astellas
Leslie Dowling | Managing Consultant, Regulatory Affairs | tranScrip
Rebecca Canter | Senior Director – Venture Sciences | Eli Lilly and Company
Agenda
15.00 – Arrival, Registration and Networking
15.30 – Welcome
15.40 – Innovation Presentations
17.20 – Refreshments and Networking
17.40 – Panel Discussion
18.40 – Closing Remarks
18.50 – Drinks Reception
19:30 – Close
Dedicated registration link here